Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 34 (Search time: 0.006 seconds).
Issue DateTitleAuthor(s)
2013Outcomes of sunitinib therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) with poor risk featuresBARROSO-SOUSA, Romualdo; MUNHOZ, Rodrigo Ramella; FONSECA, Leonardo Gomes; FEDE, Angelo Bezerra de Sousa; LINCK, Rudinei Diogo Marques; MONIZ, Camila Motta Venchiarutti; MAK, Milena Perez; SOUZA, Ciro Eduardo; HOFF, Paulo M.; DZIK, Carlos
2013Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?MIRANDA, Vanessa Costa; DIB-FARIA, Luiza; BRAGHIROLI, Maria Ignez Freitas Melro; SABBAGA, Jorge; SARAGIOTTO, Daniel Fernandes; CASTRO, Gilberto; HOFF, Paulo M.; RIECHELMANN, Rachel
2018Serum levels of VEGF and MCSF in HER2+/HER2- breast cancer patients with metronomic neoadjuvant chemotherapyARAI, Roberto J.; PETRY, Vanessa; HOFF, Paulo M.; MANO, Max S.
2019Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal CancerBURZYKOWSKI, Tomasz; COART, Elisabeth; SAAD, Everardo D.; SHI, Qian; SOMMEIJER, Dirkje W.; BOKEMEYER, Carsten; DIAZ-RUBIO, Eduardo; DOUILLARD, Jean-Yves; FALCONE, Alfredo; FUCHS, Charles S.; GOLDBERG, Richard M.; HECHT, J. Randolph; HOFF, Paulo M.; HURWITZ, Herbert; KABBINAVAR, Fairooz F.; KOOPMAN, Miriam; MAUGHAN, Timothy S.; PUNT, Cornelis J. A.; SALTZ, Leonard; SCHMOLL, Hans-Joachim; SEYMOUR, Matthew T.; TEBBUTT, Niall C.; TOURNIGAND, Christophe; CUTSEM, Eric Van; GRAMONT, Aimery de; ZALCBERG, John R.; BUYSE, Marc; ADAM, Rene; ADAMS, Richard; AJANI, Jaffer; ALLEGRA, Carmen Joseph; ANDRE, Thierry; ARNOLD, Dirk; BACHET, Jean-Baptiste; BENSON, Al Bowen; BERLIN, Jordan; BLEIBERG, Harry; BODOKY, Gyorgy; BUYSE, Marc; CHIBAUDEL, Benoist; DIAZ-RUBIO, Eduardo; DOUILLARD, Jean-Yves; ELLIS, Lee; ENG, Cathy; FALCONE, Alfredo; FRANKO, Jan; FUCHS, Charles S.; FUJII, Masashi; GIANTONIO, Bruce J.; GOLDBERG, Richard M.; GRAMONT, Aimery de; GROTHEY, Axel; HALLER, Daniel; HAMILTON, Stan R.; HAUSNER, Petr F.; HECHT, J. Randolph; HEINEMANN, Volker; HERRERA, Alain; HOCHSTER, Howard S.; JONKER, Derek J.; KAPLAN, Rick; KOEBERLE, Dieter; KOPETZ, Scott; LABIANCA, Roberto F.; LARSEN, Annette K.; LENZ, Heinz-Joseph; LIEU, Christopher; LOUVET, Christophe; LOUPAKIS, Fotios; MARSHALL, John; MAUGHAN, Timothy S.; MAYER, Robert J.; MEROPOL, Neal J.; MITCHELL, Edith P.; O'CONNELL, Michael J.; PEETERS, Marc; PORSCHEN, Rainer; PRICE, Timothy; PUNT, Cornelis J. A.; SALEM, Mohamed E.; SALTZ, Leonard; SCHILSKY, Richard; SCHMOLL, Hans-Joachim; SEYMOUR, Matthew T.; SHMUELI, Einat Shacham; SHI, Qian; SOBRERO, Alberto; SOUGLAKOS, John; TABERNERO, Josep; TAIEB, Julien; TEBBUTT, Niall C.; TEJPAR, Sabine; TEMPERO, Margaret; TOURNIGAND, Christophe; TSUJI, Yasushi; CUTSEM, Eric Van; VENOOK, Alan P.; YOSHINO, Takayuki; WEINBERG, Benjamin A.; WOLMARK, Norman; ZALCBERG, John R.
2013Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2 positive advanced or metastatic gastric (A/MGC), esophageal (EAC), or gastroesophageal (GEJ) adenocarcinoma: The LOGiC trial.HECHT, J. Randolph; BANG, Yung-Jue; QIN, Shukui; CHUNG, Hyun-Chul; XU, Jian-Ming; PARK, Joon Oh; JEZIORSKI, Krzysztof; SHPARYK, Yaroslav; HOFF, Paulo M.; SOBRERO, Alberto F.; SALMAN, Pamela; LI, Jin; PROTSENKO, Svetlana; BUYSE, Marc E.; AFENJAR, Karen; KANEKO, Tomomi; KEMNER, Allison; SANTILLANA, Sergio; PRESS, Michael F.; SLAMON, Dennis J.
2013Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial.HECHT, J. Randolph; BANG, Yung-Jue; QIN, Shukui; CHUNG, Hyun-Chul; XU, Jian-Ming; PARK, Joon Oh; JEZIORSKI, Krzysztof; SHPARYK, Yaroslav; HOFF, Paulo M.; SOBRERO, Alberto F.; SALMAN, Pamela; LI, Jin; PROTSENKO, Svetlana; BUYSE, Marc E.; AFENJAR, Karen; KANEKO, Tomomi; KEMNER, Allison; SANTILLANA, Sergio; PRESS, Michael F.; SLAMON, Dennis J.
2013Cancer patients with ECOG-PS higher than 1: Who are those who benefit of palliative chemotherapy?CAIRES-LIMA, Rafael; PROTASIO, Bruno Mendonca; CAIRES, Inacelli Queiroz de Souza; ROCHA, Lucila Soares Da Silva; OLIVEIRA, Julia Andrade De; GUERRA, Raquel Bezerra; MAK, Milena Perez; HOFF, Paulo M.; CASTRO, Gilberto
2013Clinical characteristics at diagnosis of patients who survive more than 5 years after diagnosis of metastatic colorectal cancer (mCRC).ABRAHAO, Manuel Cruz; SANTOS, Joao Paulo Velloso Medrado; PAVAN, Thayse; HOFF, Paulo M.; KATZ, Artur; SABBAGA, Jorge; AZEVEDO, Fernanda; FREITAS, Daniel; SARAGIOTTO, Daniel F.; COSTA, Frederico
2012Feasibility of two schedules of weekly paclitaxel as (neo)adjuvant treatment for patients (PTS) with HER2-negative breast cancer (BC) in the Brazilian community settingSANTANA, Iuri Amorim; OLIVEIRA, Julia Andrade De; AMARAL, Alan Alves; TESTA, Laura; LANDEIRO, Luciana Garcia; COSTA, Romulo Leopoldo de Paula; HAJIME, Marcelo; FERRARI, Marcela Simonis Martins; PETRY, Vanessa; COHN, Daniela J. B. Heinemann; HOFF, Paulo M.; MANO, Max S.
2012Metronomic chemotherapy (MC) in the neoadjuvant setting: Results of two parallel feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC) (Traq-Me and TAME)PETRY, Vanessa; LEAL, Alessandro; ARAI, Roberto J.; MARINHO, Simone; PAIVA, Marcelo; PIATO, Jose R.; ROSA, Marcio; HOFF, Paulo M.; MANO, Max S.